Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
An update from Tenaya Therapeutics (TNYA) is now available.
Tenaya Therapeutics has announced leadership transitions with Faraz Ali taking on the role of Interim Principal Financial Officer (PFO) and Chihiro Saito stepping in as Interim Principal Accounting Officer (PAO), both effective August 14, 2024. Ali, the current CEO, has a clear track record detailed in the company’s proxy statement, and Saito brings extensive financial experience from senior roles at Gilead Sciences and McKesson Corporation. Both appointments come with no new compensation arrangements or conflicts of interest, ensuring a stable financial leadership during the transition period.
Learn more about TNYA stock on TipRanks’ Stock Analysis page.
